ABSTRACT
INTRODUCTION
The identification of peptides derived from complex mixtures of proteins is a prerequisite for several high-throughput proteomics technologies (Gavin et al., 2002; Ho et al., 2002; Link et al., 1999; Pasa-Tolic et al., 1999) . Typically, protein mixtures are digested with trypsin and the resulting peptides are sequenced using tandem mass spectrometry (MS/MS). The sequence information provided by MS/MS analysis ideally consists of sequential mass-to-charge ratios (m/z, in units * To whom correspondence should be addressed.
of Th) of the peptide as it fragments along the peptide backbone. The analytical challenge is how to use this sequence information in order to identify the unknown peptide.
In general, two approaches have been proposed for the solution of this problem. In the first, the MS/MS spectrum of an unknown peptide is compared with idealized spectra derived from genomic databases (Eriksson et al., 2000; Eng et al., 1994; Mann and Wilm, 1994) . This method will fail to find a correct answer if the peptide sequence under investigation is unavailable in the search database due to differences in the genomes of the organism studied in the field and the one sequenced, frame shifts that occur during translation, alternative splicing or post-translational modifications.
The second approach attempts to find an amino acid sequence that would produce the spectrum at hand without referring to an archive of previously available peptide sequences. This de novo methodology uses only the peaks in the spectrum to deduce the sequence of amino acids that gave rise to it and is usually stated in a graph-theoretical framework (Bartels, 1990; Dancik et al., 1999; Taylor and Johnson, 1997; Hines et al., 1992; Chen et al., 2001) .
To illustrate, consider the peptide LFSQVGK (Kinter and Sherman, 2000) . A complete and perfect fragmentation of this peptide into singly charged b-and y-ions would produce peaks at the positions shown in Figure 1 . The information contained in Figure 1 can be used to reconstruct the original peptide because the difference (in mass/charge, or m/z, units) between adjacent peaks of the same ion type corresponds to the mass of an amino acid residue in the original sequence for fragments with a charge of +1. If fragmentation occurs at every amino acid and every resulting fragment is detected as a singly charged ion, the problem of reconstructing the peptide using spectral information is greatly simplified and can be solved efficiently using dynamic programming methods (Dancik et al., 1999; Chen et al., 2001) .
Unfortunately, experimental results are seldom this perfect and the researcher is usually confronted with spectra that contain missing or unclearly defined peaks. Real spectra may also show peaks from a variety of other peptide fragments as well as considerable background noise. Departures from perfect behavior make the computationally efficient dynamic programming algorithms lose their edge when dealing with real spectral data. In the absence of clear peak identification, there is no guarantee that the graph-theoretical methods will produce the correct answer. However, determining the correct sequence of amino acids for a peptide from MS/MS spectral data can also be stated as a more general optimization problem where the objective is to match an experimental spectrum with the amino acid sequence most likely to produce it without necessarily having to recur to a graph-theoretical framework. In this paper, we present a Genetic Algorithm (GA) as an alternative to the traditional de novo sequencing approach. GAs have become an increasingly popular methodology to solve difficult combinatorial optimization problems in many different areas of science and engineering. Pioneered in the 1970s by Holland (1992) , GAs work by combining small blocks of relevant information to progressively create better solutions. Since GAs require only the assignment of a goodness value to any given solution, they are not deterred by discontinuities in the search space, noisy objective functions or non-linearly constrained spaces.
SYSTEMS AND METHODS

Specific approach for MS/MS data
The implementation of our GA starts with a small initial population of amino acid sequences generated at random. These sequences are manipulated using mechanisms of recombination, selection and mutation until some criterion of convergence has been met.
Development of the fitness function
In most optimization problems, the objective or objectives, can usually be clearly stated as mathematical functions or some combination of rules to be followed or decisions to be made under appropriate circumstances. In the case of MS/MS spectra, all we know is that the end result should be a complete sequence whose mass and main spectral features match those in the experimental spectrum.
We could ask whether pursuing these objectives (total peptide mass and spectral peaks) individually may provide the algorithm with enough guidance to obtain a correct answer. An objective function that uses only total peptide mass as target will often result in a solution that matches the target mass well but has an incorrect sequence of amino acids. Direct comparison of features between spectra (the target and that from a potential solution) can also fail to produce the desired result because spectra from peptides that are structurally alike can be very dissimilar. The solution must ultimately match the target mass and target spectral features, but these cannot be the only guides during the search. The fitness function in this paper employs total peptide mass and target spectral features as part of a multiple-objective approach, but it is supplemented by a term that provides information about the similarity between two spectra. This similarity term counts the number of peaks between two spectra that could be matched by an appropriate translation. Efforts to derive similarity measures among mutated and modified peptides have been presented in the work of Pevzner et al. (2000 Pevzner et al. ( , 2001 . We develop a methodology to measure peptide similarities analogous to the cited references, but one that is adapted specifically for the GA.
Our objective function can be written as fitness = w 1 · match peaks − w 2 · non match peaks
where w 1 , w 2 , w 3 and w 4 are empirical constants whose magnitude can be adjusted to alter the relative importance of every term in the fitness function; target is the target parent peptide mass and wt is the total mass of the peptide under evaluation. The first two terms in the objective function measure how well the target spectrum matches the one produced by a candidate peptide. These terms reward features of a potential solution that match peaks (within some tolerance) in the target spectrum and penalize unmatched peaks. In this paper, we consider complete fragmentation of the peptide representing the potential answer into b-and y-ion fragments only, but other ion types can also be considered. The third term penalizes deviations from target mass. The first three terms in the objective function are traditional, and relatively simple, measures of similarity between spectra.
However, these three terms alone can in many cases fail to identify peptide chains that are nearly identical to the one that produced the target spectrum and are, for this reason, of limited help to the GA. The spectra of two peptides that differ by a single amino acid can potentially result in more nonmatching spectral features (including total mass) than spectra produced by amino acid chains whose contents differ in more dramatic ways. This means that the first three terms in the objective function can drastically drop a solution from a high fitness value by a change of a single amino acid in the correct sequence. From this, it follows that we need to supply our fitness function with a way to discriminate between peptides that are at least partially good matches for our target from those that are not.
To this end, we introduce a fourth term in the fitness function in an attempt to derive a measure of overall similarity between two spectra. Consider an experimental spectrum whose m/z values can be described as a set of m peaks, S = {s 1 , s 2 , s 3 , . . . , s m } (possibly consisting of more than band y-series ions), and the simulated spectrum of a potential solution, P = {p 1 , p 2 , p 3 , . . . , p n } (as used in this paper, consisting of b-and y-series ions only), as a set of n peaks. Computing the differences between m/z values of every peak in S and every peak P in results in an m by n matrix of dif-
whose entries can be inspected to find peaks in P that, if translated, would match those in S. If every entry in D has a distinct numerical value, it is not possible to simultaneously match more than one peak between P and S when adding a single real number to all the m/z entries of either spectrum. On the other hand, if multiple entries in D have the same numerical value (within a certain tolerance), they represent peaks in P that-either in their original position or after an appropriate translation-can be made to match peaks in S simultaneously. To illustrate this concept with a trivial example, consider what would happen if the numerical entries for S and P were obtained using the same peptide chain. In that case, the matrix D would possess a large number of zeros (m, if the size of both S and P is 1 by m). If the peptide chains represented by S and P differ by a single amino acid, the D matrix formed by this new pair of sequences would probably have few zeros (depending on where the substitution has occurred) and a relatively large number of entries with a numerical value equal to the difference between the masses of the pair of amino acids involved in the dissimilarity between chains. The multiplicity of repeated entries in D can be used as an indication of the similarity level between S and P . Pevzner et al. (2000) considered cases where the shifts needed to match peaks between two spectra could be attributed to the substitution of one or two amino acid residues in the original peptide chain. Their procedure for spectral alignment is based on a dynamic programming algorithm where both spectral peaks and the masses of amino acids are approximated by integers. Their work considers only ions in the b-series since simultaneous use of b-and y-series ions (or other types of ions) can make the dynamic programming algorithm converge to infeasible solutions. In our case, we are not interested in finding a particular amino acid substitution that can be used to explain all the differences between two spectra. Instead, our aim is to use the number of repeated entries in D to help us assess the relative fitness of potential solutions to our problem. The last additive term in the objective function incorporates information regarding whether two or more peaks in the simulated spectrum of a potential solution can be simultaneously matched to those in the target spectrum by an appropriate translation. The similarity index in our objective function is defined as the number of non-distinct entries in the matrix D (within a given tolerance) divided by the total number of elements in D. This last term in the fitness function increases in value only if at least two peaks can be simultaneously matched by a translation.
As a simple test of the potential usefulness of the similarity term in the objective function, a histogram of the number of peaks that can be matched by translation (as measured by the number of non-distinct entries in the matrix D) for 10 000 independently and randomly generated amino acid sequences (with length between 7 and 10 amino acids each) and the target spectrum in Figure 1 is shown in Figure 2 . In this figure, we also show histograms of the number of non-distinct entries in the matrix D found when comparing the idealized spectrum of Figure 1 and the simulated spectra produced after one, two and three amino acid substitutions in the sequence LFSQVGK.
A large majority of the randomly generated sequences have a number of non-distinct entries in D of 30 or less. This is also true for the histogram obtained when three amino acids are simultaneously substituted in the LFSQVGK sequence. The other two cases, one and two substitutions in the correct sequence produce a distribution of non-distinct entries in D with higher mean. Considering that a change of three amino acids in LFSQVGK corresponds to alterations in over 40% of its contents, the differences in these histograms indicates that significant damage to the original peptide sequence must be done before the distribution of non-distinct entries in D resembles that seen with randomly generated amino acid chains. Ideally, we would prefer that the distributions shown in Figure 2 would not overlap at all. As it is, this figure suggests that the fourth term in the fitness function can be helpful in distinguishing sequences that are similar to the one that produced the target spectrum from those that are not.
To test the effectiveness of our approach, we employ a series of runs with three different scenarios: (1) perfect spectral information; (2) the case in which key peaks are missing; and (3) a series of real MS/MS spectra.
Perfect information. The full spectrum in Figure 1 is used as the target (using m/z values only, i.e. no intensity information is employed). Missing peaks. All combinations of one and two peaks in the spectrum shown in Figure 1 are deleted and the algorithm executed as above.
Real MS/MS spectra. In the last example, we use real spectra and compare our results with those obtained using the same input data and a de novo sequencing algorithm. The spectra were obtained from both literature and in-house MS/MS analysis at the Pacific Northwest National Laboratory in the laboratory of Richard Smith. The latter spectra were analyzed using a current best practice for identifying peptides from LCQ MS/MS data (Wolters et al., 2001) . Each peptide was analyzed multiple times on multiple days with a Finnigan ion-trap mass spectrometer and at least one spectrum for each peptide resulted in Sequest scores exceeding 2. In addition, the mass of each peptide parent ion was examined as to whether it confirmed to within one part-per-million of the theoretical mass for that peptide by the use of an 11.5 T ion-cyclotron resonance mass spectrometer and a 15% elution time tolerance (Smith et al., 2002) .
To assess the quality of the results obtained with our procedure, we have used Lutefisk Johnson, 1997, 2001 ), a de novo sequencing program, for comparison purposes. Lutefisk, one of many de novo algorithms available, was chosen in this paper due to its ease of use and access and because it is representative of the way in which many other de novo methodologies work.
In general, Lutefisk attempts to reconstruct complete peptides by extending candidate sequences, one amino acid at a time, in a way that maximizes a score function. Only sequences that match the total peptide mass (within certain tolerance) are stored. A maximum of five top-scoring 16, 147.18, 204.23, 261.34, 303.36, 348.42, 431.49, 476.55, 518.57, 575.68, 632.73, 665.75 3 965.10 147.2, 245.2, 260.3, 358.3, 423.5, 471.5, 494.6, 542.6, 607.1, 705.8, 720.9, 818.9, 965.1 4 1738.00 305.5, 324.5, 509.5, 622.5, 660.3, 676, 693.5, 776.5, 788, 821.5, 843, 860, 879, 917, 950, 1028, 1045, 1059, 1078, 1116, 1229, 1391.0, 1415.0, 1492 5 1825.90 375.1, 474.3, 520.3, 529.2, 573.5, 625.2, 679.1, 680.0, 681.4, 736.7, 745.4, 756.4, 819.7, 823.5, 832.4, 844.3, 848.2, 947.4, 948.4, 992.1, 1062.1, 1079.4, 1110.5, 1111.5, 1182.6, 1183.6, 1228.9, 1295.6, 1350.0, 1396.6, 1409.8, 1410.8, 1416.9, 1432.5, 1450.0, 1451.6, 1523.8 sequences are usually reported, although a smaller number is common. Whenever the program finds gaps in the spectrum that cannot be identified with certainty, Lutefisk inserts the mass of the gap in square brackets into the final sequence. A complete description that does full justice to the way in which Lutefisk functions is beyond the scope of this paper but the interested reader will be able to find resources in the published work Johnson, 1997, 2001) .
RESULTS AND DISCUSSION Example 1: testing the performance of the GA under conditions of perfect information
The target for our first example is the complete, perfect spectrum used in Figure 1 , consisting of the set of peak locations given in Table 1 (which shows the target spectra for this and the rest of the examples in this paper). The target mass of the full peptide is 778.91 Da, which is the m/z value of the precursor peptide (389.46) multiplied by a charge of 2. The values of the weights in the fitness function for the first example were (empirically) set to w 1 = 1, w 2 = 1, w 3 = 1 and w 4 = 20/|D|,where |D| represents the number of elements in the matrix D. A matching peak was counted if a simulated peak was within 0.01 Da of a feature in the target spectrum. The strict tolerance for counting matching spectral features was used because we know that the there is no error in the measurements of the target spectrum. Out of 1000 independently started runs with perfect information, the correct sequence was found at the end of 384 of them. These 384 correct sequences also had the highest score among all 1000. Although results from this and other examples can be used as rough indicators of performance, it should not be inferred that the rate of success of the GA is at or close to 38.4% . The actual rate at which the GA finds correct peptide sequences will depend on a variety of factors such as complexity and size of the target spectrum and the parameters used during a run.
Using Lutefisk and the same set of m/z values used for the GA, we obtained the sequences LFSKVGK, [174.0]SSKVGK and [174.0]EKSGGK, employing tolerances for total peptide mass and internal fragments of 1.00 and 0.75 Da, respectively. These tolerances seem, at first, to be overly wide considering the high quality of the input data but were the ones we found produced the best results. The best sequence reported by Lutefisk corresponds almost perfectly to the target one with the exception of a K instead of the Q present in the original sequence. These amino acids cannot be distinguished from each other, given the tolerance value used.
Example 2: missing features in an otherwise perfect spectrum
Our second scenario corresponds to a situation commonly found in practice, and a hurdle for many de novo sequencing algorithms.
One and two peaks at a time were deleted from the target spectrum in Example 1 and the resulting information entered into the GA. A total of 10 independently started runs were made after every deletion. The rest of the parameters for the algorithm were kept as those in Example 1.
In all the answers found after every group of then runs, the fitness values of the answers were highly correlated with their quality. For example, when the 114.16 entry was deleted from the original spectrum, the sequence LFSQVGK was found four times (with the highest fitness among all 10 reported answers) followed by LFSAGVGK (three times) and three other, less fit answers. Runs where a different peak was missing from the target spectrum yielded very similar results.
A summary of the number of times that the correct sequence was found in every set of 10 runs when one and two peaks in the target spectrum were missing is shown in Table 2 . The numbers shown in Table 2 do not convey a sense of the quality of the answers produced by the GA since counting only the number of perfect solutions dismisses the fact that all the peptides reported as answers could be partially matched to relatively large portions of the available data. The peptides obtained in these runs are structurally very similar to those shown in the previous paragraph.
It is apparent from the results in Table 2 that the version of the GA we propose is not automatically deterred by missing or incorrect information although, naturally, the quality of the solutions obtained will depend on the completeness and accuracy of the input data and on the parameters chosen for the algorithm. When using Lutefisk with the datasets missing one and two peaks, we obtained the results shown in Table 3 .
Since, in many cases, Lutefisk's answer consists of a single sequence, results in Table 3 indicate only if the correct peptide chain was found (i.e. if the correct peptide was among the final solutions reported, regardless of rank). Lutefisk reports LFSKVGK as the best sequence but, for reasons already mentioned, we considered this to be the correct answer. As with the GA, results in Table 3 are somewhat simplified since in most cases the chain (or chains) reported by Lutefisk matched portions of the target sequence well.
In a majority of cases in Table 3 , Lutefisk has not been able to find the correct peptide. This is not completely surprising because Lutefisk cannot bypass significant gaps present in the input data.
We now shift our attention to examples using real spectra. These examples will show how our algorithm performs on data with varying degrees of completeness, levels of noise and redundant or superfluous information.
Example 3: spectrum from the literature Snyder (2000) presents, in one of many examples, a list of observed ions in the ESI-tandem mass spectrum of the T15 tryptic fragment of equine cytochrome c, corresponding to the amino acid sequence EDLIAYLK. The locations of the observed fragment ions are given in Table 1 . This list of m/z data is an incomplete set of spectral features and was used as input to our program, along with the target mass (M +H ) of 965.1 also reported by Snyder (2000) . The weights in our objective function were set at w 1 = 1, w 2 = 0.1, w 3 = 10, w 4 = 10/|D| and the tolerance for counting a match between the target and simulated spectrum was set at 0.5 Da.
Of 40 independently started runs, the correct sequence was found on two occasions and was the highest scoring peptide among all 40 answers (final score of 22.9945). Naturally, some ambiguity remains in the final answers since our program was not able to distinguish between Ile and Leu. The top 10 distinct sequences found (in descending order of fitness) are EDLLAYLK, MLLLAYLK, MKYALLLL, MKYALPNK, MLLLHPLQ, MLLLSFLQ, MLLLAYLMLLAYLK, VAY-HAYLQ, MLLLAYLMLLAYQL and MLLLAYLLAYLK.
Note that most of the reported peptides share similar subsequences and that the stiff penalty for deviations from target weight has helped to maintain the length of most of the reported peptides within reasonable limits. The number of peaks in the target spectrum matched by each of the top 10 answers is 11, 11, 9, 9, 8, 8, 12, 8, 10 and 10, respectively.
The same m/z values were used as input for Lutefisk. Once again, tolerance levels of 1.0 Da for total peptide mass and 0.75 Da for fragment error produced the best results among our trials. A single sequence, FPLLAYLK was reported at the end of the Lutefisk run. This sequence is very close to the target one and the amino acid combination FP at the beginning of the peptide has almost the same mass as ED (the correct first two amino acids) or ML (reported in a majority of the GA solutions).
Examples 4 and 5: spectra analyzed at PNNL
Example 4. Peptides were derived from Deinococcus radiodurans by tryptic digestion and mass analyzed in the laboratory of Richard Smith at the Pacific Northwest National Laboratory. The m/z values reported in this, and all subsequent examples, were obtained after using a simple, statistically based procedure to eliminate some spectral features, possibly caused by noise, from actual MS/MS spectra . The m/z values for this example are given in Table 1 . The target mass for the parent peptide (M + H ) is 1738 Da.
For this problem, we assigned weight values of w 1 = 1, w 2 = 0.1, w 3 = 10, w 4 = 5/|D| and a tolerance of 0.75 Da for counting matching peaks. These weights slightly reduce the relative importance of the similarity term in the fitness function as compared with the value used in Example 3. The rest of the GA parameters are the same as those used in Example 1.
Sequest's identified solution is ANHWLAQGAQPTDTAR, with a total mass (M + H ) of 1737.86 Da, Cn of 0.0000 and cross-correlation equal to 4.3391. As with the remainder of the examples, the mass of the precursor ion was confirmed to be correct to within one-part-per-million of the theoretical mass for that peptide by the use of an 11.5 T ion-cyclotron resonance mass spectrometer (Smith et al., 2002) . Consideration of these two sources of evidence makes for a very strong case that the correct peptide has been identified during the database search.
The best 15 solutions out of 150 independently started runs of the GA are:
with total mass (M +H ) ranging from 1737.36 to 1738.09 Da. The middle portions of a majority of the sequences (Sequest's and those found by the GA) are very similar. This is not surprising since real spectra usually possess more information available for the reconstruction of these middle peptide fragments than those at either end of the amino acid chain. The researcher should be aware that, under these circumstances, the amino acids present at either end of a peptide created by this sequence optimization approach or de novo algorithms can probably be arranged in different ways and still match the available target features equally well.
Lutefisk's answers to this same set of m/z values (using tolerance levels of 1.0 Da for total peptide mass and 0. Peptides reported by Lutefisk match a maximum of six non-sequential amino acids in the database answer whereas several of the GA sequences match six and, in one case, seven consecutive amino acids present in the database answer. Nonetheless, it is interesting to note that several of Lutefisk's answers report the (assumed) correct last three amino acids in the sequence, TAR, which the GA has not been able to detect. The parameter file we have employed for Lutefisk specifies tryptic digestion and therefore the de novo program forces an arginine or lysine residue at the end of the peptides while the GA does not (although it could be easily modified to do so).
Example 5. This example deals with a spectrum that has redundant peak information (in the form of peak positions that are slightly more than one m/z unit apart) and a relatively large number of data points. The 10 best sequences found out of a run with 100 independent starts (using the same objective function parameters as in the previous example and a tolerance of 1 Da), are YGMVVFVGDSCLDLGPK, DDALGAHVGRSCLGPQMP, DWLNNAYNLFVVLSR, TWQNNLCCVYAAPDDPE, WTSVAPCSMFEGLLEGP, DQMPGSEVCYPVCNGQP, KDGNAVGCSDDRSSGG NAN, FLLVVYLVMCLDCYK, MENTCRLSGSCLTDYM and PDDSGGLCSDYDSCDSTS.
Compare these sequences to the one reported by Sequest (DANNNNAYDSGDVVLSR) as the highest score found by database search. Sequest's answer has a total mass (M + H ) of 1824.8 Da. The GA answers have total mass ranging from 1823.2 to 1825.1 Da. The third answer reported by the GA matches the one found in the database search relatively well (10 amino acids in the GA solution can be matched to corresponding amino acids in the database answer at roughly the same positions).
The rest of the sequences found do not have much in common with either the database answer or each other and we decided to use this opportunity to investigate the behavior of our algorithm when provided with an initial population biased toward a specific portion of the problem space. To do this, we inserted the three highest scoring sequences found by the GA in the initial population of a new set of runs. The best five sequences from 100 independently started GA runs with this biased initial population are WNNNNAYNPYVVNQN, DWLNNAYNPYVVNNQ, DWLNNAYNLFVVAGGGGG, DWLNNAYNLFVVAGNN and DWLNNAYNLFVVAGNN.
The introduction of highly fit individuals into the population has had the effect of narrowing the scope of the search and has produced nearly identical sequences after every run. The exercise of biasing the initial population is important because we plan to introduce portions of peptides generated by graph-theoretical methods Cannon and Jarman, 2003) or derived from genomic databases into the GA in the next stage of our work. We expect that introducing peptides that can be matched to portions of the target spectrum into the initial population will accelerate the rate of convergence and improve the quality of the final answers.
Lutefisk's best answers were found using tolerance levels of 1.0 Da for both total peptide mass and fragment error. Considering that the evidence at hand points to the database sequence as the correct answer, Lutefisk has found only two amino acids in the correct order (AY). This is an indication that the m/z values used as input in this example may lack crucial information (or contain too much noise) to allow the reconstruction of the complete correct sequence without recurring to a database.
COMPUTATIONAL EFFICIENCY
As we have implemented it, our version of the GA creates 350 individuals in each of 150 generations, for a total of 52 500 evaluations of the objective function before reporting an answer. Considering that at least 10 (for the simpler examples) and at most 150 independently started runs have been used to find a series of potential sequences from which a final peptide can be selected, our algorithm goes through a number of sequences ranging from a little over half a million to close to 8 million to build a small set of potentially good amino acid chains.
For the examples we have presented here, strings with at least 10 and at most 20 spaces were considered. Our set of building blocks consists of 19 different amino acids (we cannot distinguish between Leu and Ile) and a blank character. The number of distinct candidate peptide chains available under these conditions ranges from 20 10 ∼ 1.024 × 10 13 for the strings with 10 spaces to 20 20 ∼ 1.049 × 10 26 for the examples with initial chains of up to 20 spaces. This means that our algorithm has explored at most 5.13 × 10 −6 % of the available space (for the 10 amino acid chain and 10 solutions) and at most 7.51 × 10 −18 % of the space (for the 20 amino acid chain and 150 generated solutions) before reporting an answer.
One distinct advantage of the GA is that the user has the ability to choose convergence criteria prior to an actual run and therefore determine the computational effort employed in obtaining a solution.
The GA has proved that it can remain practically useful for problems which grow exponentially with the number of decision variables in the areas of reliability engineering (Coit and Smith, 1996) and experimental design (HerediaLangner et al., 2003) . This means that the algorithm has been shown to be capable of finding good answers in problems with very large spaces without using (a population that increases exponentially with the size of the problem.).
FUTURE WORK
There are several areas where improvements and further developments are possible. Our priority is combining the GA with a probability-based fitness function that allows scoring peptides on a likelihood scale . Development of a meaningful and useful scoring function is vital if a performance comparison with de novo techniques, or other peptide identification algorithms, is to take place.
CONCLUSIONS
We have used an optimization methodology that attempts to gradually construct peptide sequences that match the target spectrum optimally. The GA implemented here is not immediately deterred by incomplete spectra, peaks produced by unusually occurring peptide fragments or background noise.
